2028年までの欧州血漿分画市場予測 - 製品別(免疫グロブリン、アルブミン、凝固因子濃縮物、プロテアーゼ阻害剤、その他の血漿製品)、用途別(神経学、免疫学、血液学、救命救急、呼吸器学など)の新型コロナウイルス感染症の影響と地域分析アプリケーション）、およびエンドユーザー（病院および診療所、臨床研究研究所、学術機関）

市場紹介

ヨーロッパの血漿分画市場には、ドイツ、フランス、イギリス、スペイン、イタリア、その他のヨーロッパ諸国。ヨーロッパは世界の血漿分画市場で重要な位置を占めており、予測期間中に堅調な成長率を記録すると推定されています。この地域の市場の成長は、人口の高齢化、さまざまな慢性疾患を治療するための免疫グロブリンの使用の増加、免疫疾患および出血疾患の有病率の増加、疾患管理のための血漿療法の急増により予想されており、これらすべてが欧州地域の市場の成長を促進すると予想されています。

ヨーロッパ諸国では、神経疾患、血液疾患、呼吸器疾患などのさまざまな慢性疾患の医療行為が変化しています。医療スタッフの多様化と重症者の治療に注力する決定により、新型コロナウイルス感染症（COVID-19）の増加は病気の発見と治療に影響を与えています。現在のパンデミックのため、多くの研究機関は新型コロナウイルス感染症の研究により重点を置き、ウイルスをより深く理解するために懸命に取り組んでいます。この地域の一部の連邦機関は、新型コロナウイルス感染症患者の治療に血漿療法を率先して導入している。例えば、フランス国立医薬品保健製品安全庁（ANSM）は、免疫血漿療法が重症患者の治療に使用されると発表した。また、欧州委員会は重症患者の治療に回復期血漿療法の緊急使用を推奨した。したがって、新型コロナウイルス感染症（COVID-19）の管理における血漿療法の使用は、市場にある程度プラスの影響を与えています。しかし、新型コロナウイルス感染症（COVID-19）の影響で、神経疾患、血液疾患、特異性疾患の全体的な医療行為が変化しており、製薬会社やバイオ医薬品会社の大多数が新型コロナウイルス感染症（COVID-19）の新たな治療法の開発に重点を置いており、これが社会に悪影響を及ぼしている。市場成長。

< p>市場の概要とダイナミクス

ヨーロッパの血漿分画市場 2021年の68億2,467万米ドルから2028年までに104億295万米ドルに増加すると予想されています。 2021 年から 2028 年にかけて 6.2% の CAGR で成長すると推定されています。高齢者人口の増加、神経学、血液学、希少遺伝性疾患、自己免疫疾患などのさまざまな治療分野における免疫グロブリンの使用の増加、それに伴い管理のための血漿由来療法の需要の高まりの疾患はすべて、ヨーロッパの他の地域の血漿分画市場を押し上げると予想されています。さらに、ヨーロッパのさまざまな企業は、疾患管理のための血漿療法における新しいアプローチを開発および発売するための研究開発活動にさらに投資しています。

主要市場セグメント

ヨーロッパの血漿分画市場は、製品、アプリケーション、エンドユーザー、国に分割されています。ヨーロッパの血漿分画市場は、製品に基づいて、免疫グロブリン、アルブミン、濃縮凝固因子、プロテアーゼ阻害剤などに分類されています。免疫グロブリンセグメントは、2021年に市場で最大のシェアを握ると見込まれています。ヨーロッパの血漿分画市場は、アプリケーションに基づいて、神経学、免疫学、血液学、救急医療、呼吸器学などに分類されています。 2021 年には、神経科分野が市場で最大のシェアを握ると予想されます。ヨーロッパの血漿分画市場は、エンドユーザーに基づいて、病院や診療所、臨床研究研究所、学術機関に分割されています。 2021 年には、病院および診療所部門が市場で最大のシェアを握ると予想されます。国に基づいて、ヨーロッパの血漿分画市場はフランス、ドイツ、イタリア、スペイン、英国、およびその他のヨーロッパに分割されています。 2021 年にはヨーロッパのその他の地域が最大の市場シェアを占めました。

リストされた主要な情報源と企業

ヨーロッパの血漿分画市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業のウェブサイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに記載されている主要企業は、Bharat Serums and Vaccines Limited (BSV) です。株式会社バイオプロダクツ研究所;バイオテストAG; CSL限定。グリフォルス、SA;ケドリオン SpA;オクタファーマ AG;サンキン。そしてSKプラズマ。

購入理由レポート

span>

ヨーロッパの血漿分画市場の状況を理解し、大きなリターン。
ヨーロッパ血漿分画市場の絶え間なく変化する競争環境を理解して、競争に先んじてください。
最も売上が見込める市場セグメントを特定することで、ヨーロッパの血漿分画市場での M&A やパートナーシップ取引を効率的に計画します。
洞察力のある包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちます。ヨーロッパ血漿分画市場のさまざまなセグメントの市場パフォーマンス。
ヨーロッパ地域の 2021 年から 2028 年までのさまざまなセグメントごとの市場収益予測を取得します。

ヨーロッパ血漿分画市場セグメンテーション

ヨーロッパの血漿分画市場 - 製品別

免疫グロブリン
静脈内免疫グロブリン (IVIG)
皮下免疫グロブリン (SCIG)
アルブミン
凝固因子濃縮物
プロテアーゼ阻害剤
その他
欧州血漿分画市場 - scan>アプリケーション
神経科
免疫学
血液学
救命救急学
呼吸器学
その他
欧州血漿分画市場 - エンドユーザー別
病院および診療所
臨床研究所

学術機関
ヨーロッパの血漿分画市場 - 国別
フランス
ドイツ
イタリア
スペイン
英国
その他のヨーロッパ

ヨーロッパの血漿分画市場 - 会社概要
Bharat Serums and tobaccos Limited (BSV)
バイオプロダクツ研究所株式会社
バイオテストAG.
CSL限定
SA 州グリフォルス
Kedrion SpA
Octapharma AG
サンキン
SK プラズマ

TABLE OF CONTENTS
1.           Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        Europe Plasma Fractionation Market – By Product
1.3.2        Europe Plasma Fractionation Market – By Application
1.3.3        Europe Plasma Fractionation Market – By End User
1.3.4        Europe Plasma Fractionation Market – By Country
2.           Europe Plasma Fractionation Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           Europe Plasma Fractionation Market – Market Landscape
4.1         Overview
4.2         Europe PEST Analysis
4.3         Experts Opinion
5.           Europe Plasma Fractionation Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Plasma Therapy Being Widely Used
5.1.2        Market is Developing Due to Active Participation of the Key Players
5.2         Market Restraints
5.2.1        Alternate Non-Plasma Substitutes Available
5.3         Future Trends
5.3.1        Novel Diseases Getting Treated By Using Plasma Therapy
5.4         Impact Analysis
6.           Plasma Fractionation Market – Europe Analysis
6.1         Europe Plasma Fractionation Market Revenue Forecast and Analysis
7.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1         Overview
7.2         Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3         Immunoglobulin
7.3.1        Overview
7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1          Intravenous Immunoglobulin (IVIG)
7.3.2.1.1          Overview
7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2          Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1          Overview
7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4         Albumin
7.4.1        Overview
7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5         Coagulation Factor Concentrates
7.5.1        Overview
7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6         Protease Inhibitors
7.6.1        Overview
7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7         Other Plasma Products
7.7.1        Overview
7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1         Overview
8.2         Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3         Neurology
8.3.1        Overview
8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4         Immunology
8.4.1        Overview
8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5         Hematology
8.5.1        Overview
8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6         Critical Care
8.6.1        Overview
8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7         Pulmonology
8.7.1        Overview
8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8         Other Applications
8.8.1        Overview
8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1         Overview
9.2         Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3         Hospitals and Clinics
9.3.1        Overview
9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4         Clinical Research Laboratories
9.4.1        Overview
9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5         Academic Institutes
9.5.1        Overview
9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10.        Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1      Overview
10.1.1     Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3       Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1    Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4       Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5       Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3       France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1    France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4       France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5       France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1    UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4       UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5       UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1       Overview
10.1.1.4.2       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3       Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3.1    Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4       Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5       Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1       Overview
10.1.1.5.2       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3       Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3.1    Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4       Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5       Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1       Overview
10.1.1.6.2       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3       Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3.1    Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4       Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5       Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market
11.1      Europe: Impact Assessment Of COVID-19 Pandemic
12.        Plasma Fractionation Market–Industry Landscape
12.1      Overview
12.2      Growth Strategies Followed by Major Market Players (%)
12.3      Organic Developments
12.3.1     Overview
12.4      Inorganic developments
12.4.1     Overview
13.        Company Profiles
13.1      Biotest AG.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      Octapharma AG
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Kedrion S.p.A
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      CSL Limited
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Grifols, S.A.
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Bio Products Laboratory Ltd.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      Sanquin
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      Bharat Serums and Vaccines Limited (BSV)
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      SK Plasma
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2.             Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 3.             Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4.             Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5.             France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6.             France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7.             France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8.             France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9.             UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10.          UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11.          UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12.          UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13.          Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14.          Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15.          Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16.          Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17.          Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18.          Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19.          Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20.          Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21.          Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22.          Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 23.          Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24.          Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25.          Organic Developments Done By Companies
Table 26.          Inorganic developments done by Companies
Table 27.          Glossary of Terms, Plasma Fractionation Market

LIST OF FIGURES
Figure 1.           Europe Plasma Fractionation Market Segmentation
Figure 2.           Europe Plasma Fractionation Market Segmentation, By Country
Figure 3.           Europe Plasma Fractionation Market Overview
Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market
Figure 5.           Germany to Show Significant Growth During Forecast Period
Figure 6.           Europe and PEST Analysis
Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market
Figure 8.           Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9.           Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10.        Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13.        Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14.        Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15.        Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16.        Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17.        Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18.        Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19.        Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20.        Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21.        Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22.        Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23.        Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24.        Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25.        Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26.        Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27.        Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28.        Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29.        Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30.        Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31.        France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32.        UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33.        Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34.        Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35.        Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36.        Impact of COVID-19 Pandemic in European Country Markets
Figure 37.          Growth Strategies Followed by Major Market Players (%)

Bharat Serums and Vaccines Limited (BSV)
Bio Products Laboratory Ltd.
Biotest AG.
CSL Limited
Grifols, S.A.
Kedrion S.p.A
Octapharma AG
Sanquin
SK Plasma

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022

Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022

Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.